• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

News

Article

April 25, 2025

Survey Respondents Report Dietary Modifications Help Relieve Endometriosis-Related Pain

Author(s):

Gillian McGovern, Associate Editor

Key Takeaways

  • Endometriosis is a neuroinflammatory disorder with limited treatment options, primarily hormone-suppressive drugs or surgeries.
  • Dietary modifications and supplements may provide symptom relief, with significant pain score differences observed in those reporting improvement.
  • Many patients reported benefits from reducing alcohol, gluten, dairy, and caffeine, highlighting the potential of non-hormonal strategies.
  • Further research is needed to explore the role of diet and gut microbiome in managing endometriosis-associated pain.
SHOW MORE

Although participants noted symptom relief, there was not a dietary modification uniquely perceived as beneficial.

Data published in JAMA Network Open shows that modifications to diet may help individuals manage endometriosis-associated pain. Despite these positive implications, the authors observed that no single medication was uniquely perceived as beneficial, and in some patients, there were not any helpful changes.1

Endometriosis diagnosis -- Image credit: H_Ko | stock.adobe.com

Image credit: H_Ko | stock.adobe.com

Endometriosis is a neuroinflammatory reproductive disorder in which lesions similar to the endometrium form outside of the uterus. A common symptom is chronic pain, but patients can also experience fatigue, infertility, and gastrointestinal symptoms, such as irritable bowel syndrome and abdominal bloating and pain. It is difficult to diagnose and treat, with current therapeutic options being largely limited to hormone-suppressive drugs or surgeries.1

Because the gut microbiome has been implicated as a regulator of pain related to inflammatory conditions, including endometriosis, the study investigators assessed whether dietary modifications can help provide patients with some symptom relief. The investigators utilized an online survey to gain insights into which dietary modifications and/or supplements were believed to be beneficial for pain management in patients with endometriosis. The survey was conducted between June 10 and September 2, 2022, and consisted of 24 questions written in English on the online platform Qualtrics. Statistical comparisons of distributions were performed using the Mann-Whitney U test, according to the authors.1

“Women are in need of anything that can help with the pain of endometriosis. This condition is so under-researched, and there is so much to discover, but there is growing evidence that gut bacteria could play a part in symptoms, and that explains why many women have experimented with changing their diets and why we have found that this appears to work for many,” study leader Francesca Hearn-Yeates, PhD researcher, University of Edinburgh, said in a news release.2

Among the 2858 participants who initiated the survey, 2599 had completed over 80% of the questions, and 2388 had a confirmed diagnosis of endometriosis, of which the majority (88.4%; n = 2110) were White. Additionally, most respondents reported frequent pelvic pain (96.9%; n = 2313) and abdominal bloating (91.2%; n = 2177), and about 83.8% (n = 2001) had reported trying 1 or more diets to better manage their symptoms. About 58.8% (n = 1404) of survey responders had also used supplements, with 66.9% (n= 1339) and 43.4% (n = 609) reporting self-help strategies had improved their pain.1

When respondents’ pain scores (0–10 scale) were represented on a histogram, there was a statistically significant difference between those who reported the modification had improved pain compared with those who did not, according to the investigators. Specifically, the former had lower pain scores than the latter (improvement from dietary modification: median [IQR], 4.0 [3.0-6.0]; vs no improvement: 5.0 [4.0-7.0]; P < .001).1

“This study provides valuable insights into the lived experiences of individuals with endometriosis who have explored dietary modifications and supplements to manage their pain. While it cannot assess causality, the findings highlight the need for further rigorous research into these potential non-hormonal strategies,” Nilufer Rahmioglu, PhD, MSc, senior research scientist at Nuffield Department of Women’s and Reproductive Health, University of Oxford, explained in the news release.2

Further, pain improvement was reported by 53.2% (n = 666 of 1252) of those who reduced alcohol, 45.4% (n = 523 of 1151) of those who reduced gluten, 45.2% (n = 512 of 1132) of those who reduced dairy, and 43.4% (n = 473 of 1091) of those who reduced caffeine. The low-fermentable oligosaccharides, disaccharides, monosaccharides, and polyols diet was found to be less popular (32.1%; n = 181 of 563). Additionally, among the 812 respondents who used magnesium, approximately 32.3% (n = 262) reported a benefit. Survey respondents also reported that they were likely to attempt different dietary habits because of advice from social media or a health care professional.1

“It really feels like we are on the cusp of something pretty big with understanding how diet affects endometriosis symptoms. It is so important for women, if they feel they can do something for themselves, to tackle the pain of endometriosis—that is tremendously empowering,” senior study author Philippa Saunders, PhD, FMedSci, professor of reproductive steroids at the University of Edinburgh, said in a news release.2

REFERENCES
1. Hearn-Yeates F, Edgley K, Horne AW, O’Mahony SM, Saunders PTK. Dietary Modification and Supplement Use For Endometriosis Pain. JAMA Netw Open. 2025;8(3):e253152. doi:10.1001/jamanetworkopen.2025.3152
2. The Guardian. Major endometriosis study reveals impact of gluten, coffee, dairy and alcohol. News release. April 5, 2025. Accessed April 24, 2025. https://www.theguardian.com/society/2025/apr/05/major-endometriosis-study-reveals-impact-of-gluten-coffee-dairy-and-alcohol
Related Videos
Happy elderly patient with medical health checkup with cardiologist or geriatric doctor. Senior old aging woman with coronary artery heart disease or cardiac illness check-up in clinic - Image credit: Chinnapong | stock.adobe.com
Pharmacist and patient in a retail/community pharmacy setting -- Image credit: Zamrznuti tonovi | stock.adobe.com
Menoapuse spelled with wooden blocks -- Image credit: loran4a | stock.adobe.com
Related Content
Advertisement
Used empty packaging from pills close up. Many different pill blister silver pharmaceutical packaging foils. Drug shortage concept - Image credit: Sopear | stock.adobe.com
May 15th 2025

Medication Meltdown: Unpacking Drug Shortages

Kortney J. Knudsen, BS
Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management
May 6th 2025

Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
X-ray image depicting a migraine -- Image credit: peterschreiber.media | stock.adobe.com
May 15th 2025

FDA Approves Brekiya, First and Only DHE Autoinjector, for Acute Treatment of Migraine, Cluster Headaches

Gillian McGovern, Associate Editor
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
March 31st 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
Zepbound (tirzepatide) -- Image credit: Douglas | stock.adobe.com
May 14th 2025

CVS Health Announces It Will Drop Zepbound and Prioritize Coverage of Wegovy

Gillian McGovern, Associate Editor
New OTC Option Offers Patients Itch Relief During Summer Activities
May 14th 2025

New OTC Option Offers Patients Itch Relief During Summer Activities

Aislinn Antrim, Managing Editor
Related Content
Advertisement
Used empty packaging from pills close up. Many different pill blister silver pharmaceutical packaging foils. Drug shortage concept - Image credit: Sopear | stock.adobe.com
May 15th 2025

Medication Meltdown: Unpacking Drug Shortages

Kortney J. Knudsen, BS
Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management
May 6th 2025

Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
X-ray image depicting a migraine -- Image credit: peterschreiber.media | stock.adobe.com
May 15th 2025

FDA Approves Brekiya, First and Only DHE Autoinjector, for Acute Treatment of Migraine, Cluster Headaches

Gillian McGovern, Associate Editor
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
March 31st 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
Zepbound (tirzepatide) -- Image credit: Douglas | stock.adobe.com
May 14th 2025

CVS Health Announces It Will Drop Zepbound and Prioritize Coverage of Wegovy

Gillian McGovern, Associate Editor
New OTC Option Offers Patients Itch Relief During Summer Activities
May 14th 2025

New OTC Option Offers Patients Itch Relief During Summer Activities

Aislinn Antrim, Managing Editor
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.